Pictured: Michael Berger & David Solit
Cancer Genomics: New Technologies Speed Discovery and Expand Opportunities for Personalized Medicine

At Memorial Sloan Kettering, new technologies to study gene changes in cancer cells are accelerating the development and implementation of more-effective treatments.

Monday, November 26, 2012
Pictured: Scott Lowe
At Work: Biologist Scott Lowe, Chair of the Geoffrey Beene Cancer Research Center

In the lab of cancer biologist Scott Lowe, researchers are investigating the processes that naturally inhibit cancer development.

Monday, November 19, 2012
Pictured: PET Scan
New Imaging Agent Could Improve Prostate Cancer Diagnosis and Treatment

Researchers at Memorial Sloan Kettering are developing a new strategy for PET imaging of tumors that could result in new tools to detect and monitor prostate cancer.

Thursday, November 15, 2012
Pictured: Ping Chi
At Work: Physician-Scientist Ping Chi

Dr. Chi, a physician-scientist and member of the Human Oncology and Pathogenesis Program, studies genetic and epigenetic changes that cause cancer.

Friday, November 2, 2012
Pictured: Zuckerman Research Center
Pioneering Cancer Research Complex Nears Completion

Memorial Sloan Kettering’s new research complex contains more than 100 laboratories, nearly doubling the space we dedicate to research to better understand and treat cancer.

Wednesday, October 17, 2012
Pictured: Structure of Synthesized Erythropoietin
Memorial Sloan Kettering Investigators Synthesize Vital Biological Molecule Erythropoietin for the First Time

Researchers have produced a fully synthetic, functional version of erythropoietin, the hormone that controls production of red blood cells.

Monday, October 8, 2012
Pictured: Robert Bowman
Gerstner Sloan Kettering Students Receive Kirschstein Awards

Four students have been awarded 2012 Ruth L. Kirschstein National Research Service Awards from the National Cancer Institute.

Monday, October 1, 2012
Pictured: Alexander Rudensky
Alexander Rudensky Appointed Immunology Program Chair

Dr. Rudensky studies the development of white blood cells called T lymphocytes, which participate in the immune system response to infection. He joined the Sloan Kettering Institute in 2009.

Wednesday, September 26, 2012
Pictured: Tunneling Nanotubes
Tunneling Nanotubes Connect Cancer Cells

Memorial Sloan Kettering researchers have discovered a way that cancer cells may be able to exchange information by establishing long bridges between cells called tunneling nanotubes.

Wednesday, September 19, 2012
Two Memorial Sloan Kettering Studies Focus on Role of Antibiotics in Stem Cell Transplantation

Researchers examined how changes in the microbiota may make patients more susceptible to severe infections and other complications.

Thursday, September 13, 2012